Palliative Care Costs for Outpatient Setting Management in Catalunya
CoCPAC
Palliative Care Costs for Oncologic and Non-oncologic Patients Under Different Outpatient Management in Catalunya
1 other identifier
observational
100
0 countries
N/A
Brief Summary
Cost-of-illness studies in palliative care (PC) are a growing area of interest in health economics activity. They are, in part, stakeholders' basis for deciding the allocation of the scarce public and private economic resources. There is no standard methodology to capture the formal and informal costs and expenses that health services and patients and their caregivers make during the PC attention period due to non-standard health services, and data capture approaches.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2023
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 31, 2022
CompletedFirst Posted
Study publicly available on registry
June 9, 2022
CompletedStudy Start
First participant enrolled
April 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2024
CompletedMarch 17, 2023
May 1, 2022
9 months
May 31, 2022
March 16, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Determination of economic burden (costs) of palliative care in the outpatient context.
Calculation and report the economic burden (i.e., total costs) of outpatient palliative care services, medications and procedures covered and financed by the healthcare system alongside with those covered by the patients and their families/caregivers during the last six (6) months of life (in adult patients with lung, colorectal and breast neoplasms and with terminal cardiac heart failure \[CHF\] and chronic obstructive pulmonary disease \[COPD\]).
6 months
Secondary Outcomes (2)
Type of costs.
6 months
Differentiate and compare costs.
6 months -1 year
Eligibility Criteria
Patients with a history of breast, lung, and colorectal neoplasm or Chronic Heart Failure (CHF) or Chronic Obstructive Pulmonary Disease (COPD), managed in the outpatient/domiciliary scenarios and their families/caregivers.
You may qualify if:
- Clinical diagnosis of breast, lung, and colorectal neoplasm or Chronic Heart Failure (CHF) or Chronic Obstructive Pulmonary Disease (COPD).
- Patient and caregivers must be able to maintain a 1-hour telephonic interview.
- Patient and caregivers must allow one (1) more telephone call to revise data.
You may not qualify if:
- Cases with an open legal process.
- Family/caregivers of patients that can't communicate in fluent Spanish or Catalan.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 31, 2022
First Posted
June 9, 2022
Study Start
April 1, 2023
Primary Completion
December 31, 2023
Study Completion
March 31, 2024
Last Updated
March 17, 2023
Record last verified: 2022-05